Psilocybin microdosing in the United States with Michelle Priest

Psilocybin microdosing in the United States with Michelle Priest

In this episode, Dr Elle Wadsworth talks to Dr Michelle Priest, a research project specialist at RAND, US. The interview covers Michelle’s data insight looking at psilocybin microdosing in the US with insights from a nationally representative survey.

  • What is microdosing? [01:09]
  • The importance of looking at the prevalence of microdosing psilocybin in the US [02:52]
  • The state and local policy landscape of psilocybin in the US [03:35]
  • The nationally representative survey that Michelle and colleagues used [06:20]
  • The key findings of the study [07:15]
  • The reasons for microdosing psilocybin [08:26]
  • The temporality of the microdosing questions [09:30]
  • Why people didn’t know whether they microdosed [10:36]
  • Who is microdosing psilocybin [12:02]
  • Some surprising findings from the study [12:55]
  • The implications of the findings for policy [14:00]
  • The next steps in the RAND team for psychedelics [14:29]
  • The take home messages of the study [15:32]

About Elle Wadsworth: Elle is an research fellow with the Society for the Study of Addiction. She is based at the University of Bath with the Addiction and Mental Health Group and her research interests include drug policy, cannabis legalisation, and public health.

About Michelle Priest: Michelle is a policy researcher at RAND, a nonprofit, nonpartisan research organization committed to the public interest. Her work focuses on the regulation of emerging markets, especially psychedelic substances. Michelle is a mixed methods researcher with specialized skills in human-centered design and survey methodology. She has B.A.s in economics and linguistics from the University of California, Los Angeles as well as an M.Phil. and Ph.D. in policy analysis from the RAND School of Public Policy.

Original article: Psilocybin microdosing in the United States: Insights from a nationally representative survey https://doi.org/10.1111/add.70368

The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.

The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.

Music by Jack Shakespeare.

Hosted on Acast. See acast.com/privacy for more information.

Episoder(126)

Psilocybin's potential in treating methamphetamine use disorder with Jonathan Brett

Psilocybin's potential in treating methamphetamine use disorder with Jonathan Brett

In this episode, Dr Elle Wadsworth talks to Professor Jonathan Brett, a senior consultant at St. Vincent’s Hospital, Sydney, clinical director of the Psychiatry and Non-Prescription Drug and Alcohol U...

6 Mar 19min

Ultra-processed food addiction in older US adults with Lucy Loch

Ultra-processed food addiction in older US adults with Lucy Loch

In this episode, Dr Tsen Vei Lim speaks to Lucy Loch, a doctoral candidate in the Department of Psychology at the University of Michigan, US. The interview covers Lucy’s research article on ultra-proc...

27 Feb 15min

Intersectionality in smoking cessation with Jonathan Bricker

Intersectionality in smoking cessation with Jonathan Bricker

In this episode, Annika Theodoulou speaks to Professor Jonathan Bricker, a Professor of Public Health at the Fred Hutchinson Cancer Research Center and Affiliate Professor of Psychiatry at the Univers...

20 Feb 17min

Estimating risk of cannabis use disorder using standard THC units with Rachel Lees Thorne and Tom Freeman

Estimating risk of cannabis use disorder using standard THC units with Rachel Lees Thorne and Tom Freeman

In this episode, Dr Elle Wadsworth talks to Dr Rachel Lees Thorne, a postdoctoral research associate and Professor Tom Freeman, a professor of psychology, both from the Addiction and Mental Health Gro...

13 Feb 16min

Smoking cessation among adults with substance use problems with Olufemi Erinoso and Jennifer Pearson

Smoking cessation among adults with substance use problems with Olufemi Erinoso and Jennifer Pearson

In this episode, Dr Zoe Swithenbank speaks to Dr Olufemi Erinoso, a postdoctoral fellow at the Massachusetts General Hospital and Dr Jennifer Pearson, an Associate Professor in the School of Public He...

6 Feb 18min

Psilocybin therapy for alcohol use disorder and depression with Amandine Luquiens

Psilocybin therapy for alcohol use disorder and depression with Amandine Luquiens

In this episode, Dr Tsen Vei Lim speaks to Professor Amandine Luquiens, a psychiatrist and addiction specialist at the University of Montpellier and the Addiction Department of Nîmes University Hospit...

30 Jan 15min

Stress and online social networks with Annica Kessling and Elisa Wegmann

Stress and online social networks with Annica Kessling and Elisa Wegmann

In this episode, Dr Tsen Vei Lim speaks to Dr Elisa Wegmann and Annica Kessling, a post-doctoral research fellow and a PhD student at the University of Duisburg-Essen, Germany. The interview covers An...

23 Jan 20min

How cognition and decision-making processes shape behaviour with Justin Mahlberg

How cognition and decision-making processes shape behaviour with Justin Mahlberg

In this episode, Dr Tsen Vei Lim speaks to Dr Justin Mahlberg, a Research Fellow at Monash University, Australia. The interview covers Justin’s research article on social cognition and decision-making...

16 Jan 20min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
liberal-halvtime
forskningno
rekommandert
sinnsyn
tomprat-med-gunnar-tjomlid
rss-paradigmepodden
villmarksliv
tidlose-historier
rss-overskuddsliv
rss-inn-til-kjernen-med-sunniva-rose
fjellsportpodden
nevropodden
nordnorsk-historie
kvinnehelsepodden
dekodet-2
rss-nysgjerrige-norge
rss-rekommandert